On Tremendous success of our previous Breast Cancer Conferences, The 4th Global Insight Conference on Breast Cancer will take place in the splendid city of London, UK in July 18-20, 2019.
A special invitation is extended to international colleagues to attend and contribute to the conference. Mark your calendars now and for more details please contact us at breastcancer@innovinc.org
To Meet renowned speakers, world's leading CEO's, Directors, decision and policy makers. To know about the ongoing research projects for Breast Cancer Research. To keep abreast of all advances in Breast Cancer. Chance to collaborate research organizations with industries.To share the research ideas and implement them in Breast Cancer diagnosis & Treatment. Best opportunity to reach the largest assemblage of participants from Breast Cancer Socities.
Our conferences are about you, our clients, so we work for unqualified success and we do that quietly, professionally and impeccably. We've built a reputation for creating and delivering inspirational conferences and executing them flawlessly first time round. We work really hard to achieve this and our success is down to the dynamics of a team who are down-to-earth.
INNOVINC conferences cover a broad range of research in the area of life science and technology. Attending a Innovinc Conference will provide immense access to ground-breaking research presentations and discussions which provides the best break to develop collaborations, get innovative ideas and opportunity for your own work.
On Tremendous success of our previous Breast Cancer Conferences, The 4th Global Insight Conference on Breast Cancer will take place in the gorgeous city of London, UK in July 18- 20, 2019. Breast Cancer-2019 is designed to be a relaxed and friendly meeting where delegates and invited speakers have a chance to interact on both a scientific and social basis. Breast cancer represents the front runner in cancer research in many aspects. The Programme of this Conference includes lectures on molecular characterization, epidemiology, detection and diagnosis, metastatic breast cancer, updated treatments of early and advanced disease, surgery & radiotherapy, management of difficult cases and herary syndromes.
We welcome medical oncologists, pathologists, breast surgeons, radiation oncologists and basic scientists to listen to breast cancer leaders and to exchange experiences in a friendly atmosphere. Taking advantage of the unique offerings of London, there will be a huge number of attractive options for those wishing to extend their stay and bring their families with pre and post tours of London. Leisure time activities for delegates and guests will be offered to take full advantage of London.
DOWNLOAD BROCHURE
Conference sessions may be geared toward participants with different levels of experience or different positions. Main conference sessions include the following 18 tracks. Choose to follow one track or move between tracks to create your own personalized conference experience.
LSU Health Sciences Center, USA
Albany Medical College, USA
Manchester Breast Centre, United Kingdom
University of Colorado, USA
University of L’Aquila, Italy
University of Illinois at Chicago, USA
Ewha Womans Cancer Center for women, Korea
Innovinc International welcomes you to attend the 4th Global Insight Conference On Breast Cancer during July 18-20, 2019 at London, UK. To meet renowned speakers, world's leading CEO's, Directors, decision and policymakers.
To know about the ongoing research projects for breast cancer diagnosis and treatment. New contacts to enhance the business opportunities. Engage with high profile international and national speakers. Best opportunity to reach the largest assemblage of participants from cancer and oncology communities
Thu , Jul 18, 2019
Title: Comprehensive proteomics analysis of breast cancer cell lines as it relates to targeted osmotic lysis
Harry J Gould, LSU Health Sciences Center, USA
Title: Application of ASTRO suitability criteria and 21-gene recurrence score results in breast cancer patients treated with intraoperative radiation therapy
Barb schwartzberg, Sarah Cannon Research Institute, USA
Title: Isolated thoracic perfusion in lung metastases from breast cancer
Stefano Guadagni, University of Aquila, Italy
Title: Isolated thoracic perfusion in lung metastases from breast cancer
Acevedo Duncan Mildred, University of South Florida, USA
Title: The impact of chemotherapy modification on the outcomes of breast and ovarian cancer patients
Sigita Liutkauskienė, Lithuanian University of Health Sciences, Lithuania
Title: Intraductal Papilloma
Gabriela Boufelli, ICESP/ HC/ FMUSP, Brazil
Title: Breaking breast cancer news” with ethnic minority: a UK experience
Salma Naseem, UK
Title: Current Status of Korean Breast Cancer and New Technic Oncoplastic Surgery for Breast Cancer
Nam-Sun Paik, Ewha Womans University Cancer Center Hospital for Women, South Korea
Title: Dual Action Catch and Release Photosensitizers for Targeting Triple Negative Breast Cancer
Jeremy Kodanko, Wayne State University, USA
Title: A biology-driven technology for testing cancer drug efficacy and immunotherapies in vitro
Silvia Scaglione, IEIIT , Italy
Title: A novel non-apoptotic approach to target TNBC
Tiwari Amit K, University of Toledo, USA
Title: Breast Cancer Genetics in Latin America
Pablo Ruiz-Flores, Autonomous University of Coahuila, Mexico
Title: Antitumor Action of Amygdalin on Human Breast Cancer Cells by Selective Sensitization to Oxidative Stress
Muayad Abboud, Hashemite University, Jordan
Title: A dual action glycotherapy for treating breast cancer
Dipak K. Banerjee, University of Puerto Rico, USA
Title: Is it time to establish breast cancer as a smoking related cancer?
Inger Torhild Gram, UiT The Arctic University of Norway, Norway
Title: Surgery of the Axilla ; Less is More
Osama. Almalik, King Faisal Specialist Hospital and Research Center, Saudi Arabia
Title: Inhibition of Na+/K+ ATPase activity inhibits the proliferation, motility, and invasion of endocrine resistant breast cancer cells
Maitham Khajah, Kuwait University, Kuwait
Title: Interactions between cancer associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor positive breast cancers
Philippe P. Juin, Université de Nantes, France
Title: Neoadjuvant therapy for breast cancer treatment: an expert panel recommendation from the Brazilian Society of Breast Surgeons 2018
Fernanda Barbosa, Icesp / FMUSP / HIAE, Brazil
(16:55-17:15)SLOT AVAILABLE
Title: Thoracic manifestations of breast cancer
Ayda Hussein , Alneelain university, Sudan
This is a tentative Scientific Program and subjected to change
Fri , Jul 19, 2019
Title: ELECTRON MICROSCOPY of tumorous mitochondria in 8 cases of different biologic types of invasive mammary carcinoma
Sveta Silverman, University of Alberta, Canada
Title: Real time fusion of breast MRI and breast ultrasound: new aspects in breast cancer assessment
AMORT Birgit, University Hospital Innsbruck, Austria
Title: Update on Potential Biomarkers in Triple-Negative Breast Cancer
Yan Peng, University of Texas Southwestern Medical Center at Dallas, USA
Title: Unique Signaling Pathways in Inflammatory Breast Cancer (IBC)
Kenneth Louis van Golen, University of Delaware, USA
Title: Recommendations to reduce the risk of side effects after breast cancer surgery and treatments
Tamar Jacob, Ariel University, Israel
Title: Potential value of PHLDA gene family members as a prognostic and predictive biomarker in breast cancer
Nagai Maria Aparecida, Universidade de São Paulo, Brazil
Title: Is Axillary Web Syndrome a Risk Factor for Lymphedema?
Pedro Ferreira, Centro Hospitalar Universitário Lisboa Norte - Hospital de Santa Maria, Portugal
Title: Immunotherapy in breast cancer: A new field in the therapeutic landscape of breast cancer with many perspectives.
Nikos Mitsimponas, HYGEIA HOSPITAL, Greece
Title: Autologous Breast Reconstruction With the Latissimus Dorsi Muscle With Immediate Fat Grafting
Renata Brondi, Faculdade de Ciências Médicas Santa Casa de São Paulo, Brazil
Title: Recent advances in peptidomimetics antagonists targeting estrogen receptor α-coactivator interaction in cancer therapy
Zigang li, Peking University Shenzhen Graduate School, China
Title: Clinical evolution and findings in bi-rads 3 lesions at the Hospital Alta Resolución
Jack Antonio Diaz Brito, HOPITAL ALTA RESOLUCION ECIJA, Spain
Title: Abscopal Effect of Breast Cancer
Azami Ayaka, Southern TOHOKU General Hospital, Japan
Title: BRCA Mutations: Cancer Risk and Genetic Testing
TMU, sc.chang, Taipei Medical University, Taiwan
Title: A Novel Fzd7 Antibody XW-19O1 Shows Promising Activity against Triple Negative Breast Cancer
Zhaoli Zhou, SUMHS, China
Title: Bevacizumab Addition in Neoadjuvant Treatment Increases the Pathological Complete Response Rates in Patients with HER-2 Negative Breast Cancer Especially Triple Negative Breast Cancer: A Meta-Analysis
Jing Zhang, Sichuan University, China
Title: Bevacizumab Addition in Neoadjuvant Treatment Increases the Pathological Complete Response Rates in Patients with HER-2 Negative Breast Cancer Especially Triple Negative Breast Cancer: A Meta-Analysis
Jing Zhang, Sichuan University, China
Title: Association of miR‐1247‐5p expression with clinicopathological parameters and prognosis in breast cancer
Peng Zhang, Peking University Shougang Hospital, China
Title: Periclitoral accessory breast tissue in a lactating woman: a case report
Yanlin Song, Sihcuan university, China
Title: Introducing novel and comprehensive models for the prediction of recurrence in breast cancer using group LASSO approach: are estimates of early and late recurrence different?
Tannaz Eghbali, Shiraz University of Medical sciences, Iran
Title: A Randomized Controlled Study of Breast Cancer Screening among Women from Faith-Based Communities in Israel: A Culturally-Tailored Intervention
Anat Freund, University of Haifa, Israel
This is a tentative Scientific Program and subject to change..
Sat , Jul 20, 2019
Title: The Use of a Microscope with Near Infrared Imaging Function in Indocyanine Green Lymphography and lymphaticovenous Anastomosis for LYPMHA Immediately post Mastectomy and Axillary Dissection and 3 years follow-up---3 Cases Report
LAN MU, Peking University People's Hospital, China
Title: Prevalence of BRCA1 and BRCA2 mutations among high risk Saudi breast cancer patients
Omalkhair Abulkhair, Al Faisal University, Saudi Arabia
Title: Potential therapeutic strategies in Cancer
Li-Pin Kao, East Carolina University, USA
Title: Primary Care Coordination with the Breast Unit of Hospital Alta Resolución Ecija
Jack Antonio Diaz Brito, HOPITAL ALTA RESOLUCION ECIJA, Spain
Title: Caregiver burden among Nigerian Informal caregivers of Women with Breast Cancer
Israel O. Gabriel, Ahmadu Bello University Teaching Hospital, Nigeria
(10:20-10:40) SLOTS AVAILABLE
Title: Changes from head to vagina after treatment affect the intimate relationship between partners?
Yun-Chen Chang, National Taiwan University, Taiwan
Title: Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer
Thuluz Meza-Menchaca, Universidad Veracruzana, Mexico
SPEAKER SLOT AVAILABLE
SPEAKER SLOT AVAILABLE
SPEAKER SLOT AVAILABLE
SPEAKER SLOT AVAILABLE
This is a tentative Scientific Program and subject to change...
Don t Miss This Amazing Conference And Opportunities
